Rejoni
Develops a hydrogel system to treat uterine health conditions and prevent scarring
$25MSeries A
Role not disclosedDC
Delos Capital
Activity from announced rounds
Activity in this selectionhealthworx-834921a0
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $83M 3 disclosed · full round size, not this investor’s share